Innovation panel. Weber honored to have dr. Anne schuchat, the center for Disease Control and prevention, and our second panelist is dr. Daniel salmon, Bloomberg School of public school. We are very honored to have the help and security interface from the World Health Organization joint joined us and he is going above and beyond the call of duty as he is alone in from australia through los angeles and took the redeye to be here this afternoon. He has come really above and beyond the call of duty. And then a final panelist is doctor irene koek, acting assistant administered for Global Health United States agency for international development. We will have a similar format of our last panel, and i would also maybe encourage the panelists if they feel the urge to ask one of their copanelist a question that just interrupt me and do it. Ask a wrong question, they just restate the question you would rather answer and go for it. What we are way behind so well probably go to audience q a much
Panel of speakers for panel two. Additionally this represents more of an institutional leadership and innovation and we have both were honored to have the center for Disease Control and prevention and our second panelist is doctor daniel professor of International Health and director of the institute of safety at the Bloomberg School of Public Health. We have or very honored to have doctor maurice are busy of the health and security interface and he is definitely gone above and beyond the call of duty as he has flown in from australia to los angeles and took the redeye to be here this afternoon. He has come above and beyond the call of duty. And then our final panelist is doctor irene coates, acting assistant and minister for Global Health agency for International Development. We will have a similar format of our last panel and i would also encourage the panelists if they feel the urge to ask a co panelist a question that just interrupts me and do it and if i asked the wrong question t
There are going to go ahead and resume. Once introduced quickly our panel of speakers. This represents more of an institutional leadership and Innovation Panel where pariente have Anne Schuchat from the center for Disease Control and dr. Daniel salmon director of the institute for vaccination safety at Johns Hopkins university. We are very hard to have that there Maurizio Barbeschi health and security interface from the World Health Organization join us and hes gone above and beyond the call of duty as he came to los angeles and took the red eye to be here this afternoon so he has gone above and beyond the call of duty. Our final panelists is that your irene koek the administrator for Global Health United States agency for international development. We are going to have a similar format for a last panel and i would also encourage the panelists if they feel the urge to ask one of their copanelists a question just interrupt me and do it and if i asked the wrong question as david said on
Some faith providers from kenya on the subject of Family Planning. So i think it is true what the first panel really emphasizes, that things are evolving and developing and this is an important moment to be exploring this further. And with this panel were eager to talk about it from the focus of the u. S. Policy perspective. And i think to begin with well turn to sandy thurman. Given your long involvement with hiv policy from the u. S. Government can you describe to us more about how pep far began partners with faithbased organizations and how that has evolved. Sure. Thank you. And thank you all for being here. It is interesting, the Faith Community has been a partner in response to hiv since the beginning of the epidemic both domestically and globally. So i think pet far was an out growth with faithbased organizations on the domestic side for a number of years. When we really began looking at the disproportionate impact of the epidemic in africa back in the late 1990s and early 2000,
Here. It is interesting, the Faith Community has been a partner in response to hiv since the beginning of the epidemic both domestically and globally. So i think pet far was an out growth with faithbased organizations on the domestic side for a number of years. When we really began looking at the disproportionate impact of the epidemic in africa back in the late 1990s and early 2000, it was a lot our interest and a lot of the pressure that was brought to bear on the u. S. Government and policymakers was from faithbased organizations who were on the ground in africa seeing the devastation that was occurring on the continent. So theyve been a natural partner for us faithbased organizations and faith backers have been a natural partner with those of us working in the hiv and aids response from the beginning. So when we began to expand the global perspective to focus on hiv and to put this in perspective, working in the white house, with the global aids budget had been 125 million a year f